Risk Assessment and Treat Compliance in Hypertension Education Trial - Full Text View

Risk Assessment and Treat Compliance in Hypertension Education Trial (RATCHET)

This study is currently recruiting participants.

Verified by Lawson Health Research Institute, June 2008

Sponsors and Collaborators:	Lawson Health Research Institute University of Western Ontario, Canada The Physicians
Information provided by:	Lawson Health Research Institute
ClinicalTrials.gov Identifier:	NCT00694239

Purpose

The RATCHET study assesses if patient knowledge of estimated cardiovascular risk at current and recommended target blood pressure levels improves compliance in the management of hypertension.

Condition	Intervention
Hypertension Dyslipidemia	Behavioral: Knowledge of Cardiovascular Risk Assessment

MedlinePlus related topics: High Blood Pressure

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double Blind (Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study
Official Title:	Evaluation of the Effect of Cardiovascular Risk Assessment in Treatment Compliance in Hypertension

Further study details as provided by Lawson Health Research Institute:

Primary Outcome Measures:

Medication Compliance [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Patient perception of cardiovascular risk [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Pilot Feasibility Study [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Blood Pressure [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Cholesterol Level [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Framingham Risk Score (stroke and coronary artery disease) [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment:	100
Study Start Date:	May 2007
Estimated Study Completion Date:	May 2009
Estimated Primary Completion Date:	May 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
B: No Intervention Standard Care
A: Experimental Risk Assessment plus standard care	Behavioral: Knowledge of Cardiovascular Risk Assessment Knowledge of Cardiovascular Risk Assessment and risk reduction at target BP, reviewed every 3-6 months.

Eligibility

Ages Eligible for Study:	30 Years to 84 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Essential hypertension (new diagnosis or established diagnosis) meeting criteria for pharmacologic therapy as defined by current guidelines

Exclusion Criteria:

Lack of written informed consent
Previous myocardial infarction
Previous stroke
Congestive heart failure
Stage 3 or greater chronic kidney disease
Pregnancy
Usage of medication bubble/blister package

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00694239

Contacts

Contact: George K Dresser, MD, PhD	519-663-3342	george.dresser@lhsc.on.ca
Contact: Bryan J Har, MD	519-685-8500 ext 19767	bhar@uwo.ca

Locations

Canada, Ontario
University of Western Ontario	Recruiting
London, Ontario, Canada, N6A 5A5
Contact: Isabel Crowley 519-663-3342 isabel.crowley@lhsc.on.ca
Principal Investigator: George Dresser, MD, PhD
Principal Investigator: Bryan J Har, MD

Sponsors and Collaborators

Lawson Health Research Institute

University of Western Ontario, Canada

The Physicians

Investigators

Principal Investigator:	Bryan J Har, MD	University of Western Ontario, Canada
Principal Investigator:	George K Dresser, PhD, MD	University of Western Ontario, Canada

More Information

Physicians Services Incorporated This link exits the ClinicalTrials.gov site

University of Western Ontario This link exits the ClinicalTrials.gov site

Responsible Party:	University of Western Ontario ( George Dresser )
Study ID Numbers:	R-07-053
Study First Received:	June 6, 2008
Last Updated:	June 6, 2008
ClinicalTrials.gov Identifier:	NCT00694239
Health Authority:	Canada: Ethics Review Committee

Keywords provided by Lawson Health Research Institute:

hypertension
compliance

Study placed in the following topic categories:

Metabolic Diseases
Vascular Diseases
Metabolic disorder

Dyslipidemias
Lipid Metabolism Disorders
Hypertension

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009